Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04518345
Title TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bhavana Bhatnagar
Indications

acute myeloid leukemia

Therapies

Dubermatinib

Azacitidine + Dubermatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST